|
Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of therapies for speech problems.
Created May 2008
Printer friendly page
| Results 1 to 13 displayed. |
| Title: |
Speech and language therapy for dysarthria due to non-progressive brain damage
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Dysarthria is a speech problem which can be caused by a number of brain disorders including conditions such as stroke and head injury. Typical features of dysarthria include slurring of speech and quiet voice volume. Psychological distress is often expe...
|
| Date: |
Mar 2005
|
| Title: |
Intervention for childhood apraxia of speech
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Children who have childhood apraxia of speech (CAS) find it very difficult to make sounds in the right order, which makes it hard for others to understand them. Communication can thus break down between speaker and listener. ...
|
| Date: |
Jul 2008
|
| Title: |
Interventions for apraxia of speech following stroke
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Patients with apraxia of speech know what they want to say, but are unable to carry out the speech movements due to their inability to programme the required sequence. For example, a patient may be able to say goodbye when leaving someone (automatic), b...
|
| Date: |
Jun 2005
|
| Title: |
Interventions for treating functional dysphonia in adults
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Functional dysphonia is characterised by an abnormal quality of voice in the absence of an identifiable lesion. People in occupations where voice use is central, like teachers, are more at risk of developing functional dysphonia. The causes of voice dis...
|
| Date: |
May 2007
|
| Title: |
Botulinum toxin injections for the treatment of spasmodic dysphonia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Botulinum toxin is currently the gold standard of treatment for patients with spasmodic dysphonia. It has been used over the past two decades to treat both adductor and abductor forms of the disorder. The results of this review of randomised controlled ...
|
| Date: |
May 2004
|
| Title: |
Systematic Reviews of Rehabilitation
|
| Publisher: |
HealthInsite Topic Page
|
| Description: |
Links to systematic reviews of the evidence for the effectiveness of types of rehabilitation.
|
| Date: |
May 2008
|
| Title: |
Speech and language therapy for aphasia following stroke
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Speech and language training and support for language impairment resulting from a stroke Language impairment (aphasia) is apparent in the first week in about one quarter of survivors of a stroke. About half of all spontaneous recovery from disabilit...
|
| Date: |
Jul 1999
|
| Title: |
Non-pharmacological therapies for dysphagia in Parkinson's disease
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
This review compared the benefits of swallowing therapy versus placebo (sham therapy) or no therapy for swallowing disorders in Parkinson's disease. Relevant trials were identified by electronic searches of 21 medical literature databases, various regis...
|
| Date: |
Nov 2000
|
| Results 1 to 13 displayed. |
|